AC Immune SA — Investor Relations & Filings
AC Immune SA is a clinical-stage biopharmaceutical company specializing in precision medicine for neurodegenerative diseases. The company pioneers novel approaches to diagnose, treat, and prevent conditions driven by misfolded proteins, including Alzheimer's disease, Parkinson's disease, and other rare indications. Its diversified pipeline includes therapeutic and diagnostic candidates developed through proprietary technology platforms. These candidates encompass various treatment modalities such as active immunotherapies, antibodies, and small molecules. The company's scientific and clinical strategies are validated through collaboration partnerships with global pharmaceutical leaders.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| FORM 6-K | 2026-05-15 | English | |
| 6-K - AC Immune SA (0001651625) (Filer) | 2026-05-12 | English | |
| 6-K - AC Immune SA (0001651625) (Filer) | 2026-04-30 | English | |
| 6-K - AC Immune SA (0001651625) (Filer) | 2026-04-30 | English | |
| 6-K - AC Immune SA (0001651625) (Filer) | 2026-04-07 | English | |
| 3 - AC Immune SA (0001651625) (Issuer) | 2026-03-20 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
14 filings
| |||||
| 46355480 | FORM 6-K | 2026-05-15 | English | ||
| 45255632 | 6-K - AC Immune SA (0001651625) (Filer) | 2026-05-12 | English | ||
| 39071943 | 6-K - AC Immune SA (0001651625) (Filer) | 2026-04-30 | English | ||
| 39071207 | 6-K - AC Immune SA (0001651625) (Filer) | 2026-04-30 | English | ||
| 33705647 | 6-K - AC Immune SA (0001651625) (Filer) | 2026-04-07 | English | ||
| 33000417 | 3 - AC Immune SA (0001651625) (Issuer) | 2026-03-20 | English | ||
| 32977834 | 3 - AC Immune SA (0001651625) (Issuer) | 2026-03-18 | English | ||
| 32977518 | 3 - AC Immune SA (0001651625) (Issuer) | 2026-03-18 | English | ||
| 32977508 | 3 - AC Immune SA (0001651625) (Issuer) | 2026-03-18 | English | ||
| 32977492 | 3 - AC Immune SA (0001651625) (Issuer) | 2026-03-18 | English | ||
| 32977448 | 3 - AC Immune SA (0001651625) (Issuer) | 2026-03-18 | English | ||
| 32977447 | 3 - AC Immune SA (0001651625) (Issuer) | 2026-03-18 | English | ||
| 31141162 | 6-K Filing | 2026-02-17 | English | ||
| 12904156 | Regulatory Filings 2026 | 2026-01-15 | English | ||
|
2025
1 filing
| |||||
| 12904157 | FORM 6-K | 2025-12-11 | English | ||
Financials
We couldn't load the financials
No data available yet
We have extracted financials for AC Immune SA, but not for this combination of statement and period. Try a different combination.
Swipe the table to view all periods, or rotate your phone for a wider view.
| Line item | ! |
|---|---|
| Definition not yet available — coming soon. |
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Aclaris Therapeutics, Inc.
Clinical-stage biopharmaceutical company developing drugs f…
|
ACRS | US | Manufacturing |
|
Acrivon Therapeutics, Inc.
Clinical-stage biopharma using proteomics to develop precis…
|
ACRV | US | Manufacturing |
|
ACRUX LIMITED
Develops and commercializes topical and transdermal drug de…
|
ACR | AU | Manufacturing |
|
Acticor Biotech
Develops treatments for thrombotic diseases, focusing on ac…
|
ALACT | FR | Manufacturing |
|
Actinium Pharmaceuticals, Inc.
Clinical-stage company developing targeted radiotherapies f…
|
ATNM | US | Manufacturing |
|
ACTUATE THERAPEUTICS, INC.
Clinical-stage biopharma developing therapies for cancers w…
|
ACTU | US | Manufacturing |
|
AcuCort AB
Develops user-friendly drug formulations for severe and acu…
|
ACUC | SE | Manufacturing |
|
Acumen Pharmaceuticals, Inc.
Clinical-stage biopharma developing targeted therapies for …
|
ABOS | US | Manufacturing |
|
Acurx Pharmaceuticals, Inc.
Clinical-stage biopharma developing a new class of antibiot…
|
ACXP | US | Manufacturing |
|
Adaptimmune Therapeutics PLC
Commercial-stage biopharma developing TCR T-cell therapies …
|
ADAP | GB | Manufacturing |
AC Immune SA via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33296/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33296 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33296 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33296 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33296}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for AC Immune SA (id: 33296)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.